This page is part of the Quality Measure STU2 for FHIR R4 Implementation Guide (v3.0.0: STU3) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Draft as of 2022-02-22 |
Id: | BCSComponent | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Url: | http://hl7.org/fhir/us/cqfmeasures/Measure/BCSComponent | ||||||||||
Version: | 0.0.001 | ||||||||||
Name: | BCSComponent | ||||||||||
Title: | Breast Cancer Screening | ||||||||||
Status: | draft | ||||||||||
Experimental: | true | ||||||||||
Scoring: |
system: http://terminology.hl7.org/CodeSystem/measure-scoring code: proportion display: Proportion |
||||||||||
Improvement Notation: |
system: http://terminology.hl7.org/CodeSystem/measure-improvement-notation code: increase |
||||||||||
Type: |
system: http://terminology.hl7.org/CodeSystem/measure-type code: process |
||||||||||
Date: | 2022-02-22T11:37:03-06:00 | ||||||||||
Publisher: | Clinical Quality Information WG | ||||||||||
Description: | This is an example only. | ||||||||||
Supplemental Data: |
|
||||||||||
Jurisdiction: | US | ||||||||||
Effective Period: | 2022-01-01..2022-12-31 |